RBL2/p130: a direct AKT substrate and mediator of AKT inhibition-induced apoptosis

Oncoscience. 2018 Aug 28;5(11-12):278-280. doi: 10.18632/oncoscience.467. eCollection 2018 Nov.

¹ Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, PA 19122, USA; Department of Medicine, Surgery and Neuroscience, University of Siena, 53100, Siena, Italy.

No abstract available

Keywords: AKT; RBL2/p130; apoptosis; lung cancer; mesothelioma.